Cargando…
The Role of PPAR and Its Cross-Talk with CAR and LXR in Obesity and Atherosclerosis
The prevalence of obesity and atherosclerosis has substantially increased worldwide over the past several decades. Peroxisome proliferator-activated receptors (PPARs), as fatty acids sensors, have been therapeutic targets in several human lipid metabolic diseases, such as obesity, atherosclerosis, d...
Autores principales: | Xu, Pengfei, Zhai, Yonggong, Wang, Jing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5979375/ https://www.ncbi.nlm.nih.gov/pubmed/29690611 http://dx.doi.org/10.3390/ijms19041260 |
Ejemplares similares
-
PPARs as Nuclear Receptors for Nutrient and Energy Metabolism
por: Hong, Fan, et al.
Publicado: (2019) -
The Role of Lipid Sensing Nuclear Receptors (PPARs and LXR) and Metabolic Lipases in Obesity, Diabetes and NAFLD
por: Dixon, Emmanuel D., et al.
Publicado: (2021) -
Sini Decoction Intervention on Atherosclerosis via PPARγ-LXRα-ABCA1 Pathway in Rabbits
por: Ju, Shicong, et al.
Publicado: (2018) -
Quercetin protects against atherosclerosis by regulating the expression of PCSK9, CD36, PPARγ, LXRα and ABCA1
por: Jia, Qingling, et al.
Publicado: (2019) -
Inhibiting LXRα phosphorylation in hematopoietic cells reduces inflammation and attenuates atherosclerosis and obesity in mice
por: Voisin, Maud, et al.
Publicado: (2021)